Company: CI
Filing Date: 2025-09-02
Form Type: 424B5
Source: 0001140361-25-033574
Chunk: 13

Company: Cigna Group
Filing Date: 2025-09-02
Form: 424B5
Chunk 13
---
 therein and those terms made part thereof by the Trust Indenture Act. In this “Description of the Notes” section, when we refer to the “Company,” “we,” “our” or “us,” we refer to The Cigna Group and any successor obligor and not to any of its subsidiaries. The Indenture does not restrict our ability to incur additional indebtedness, other than certain indebtedness secured by liens on common stock of our Designated Subsidiaries. The Indenture contains negative covenants that apply to us; however, these covenants contain important exceptions. See “Description of Debt Securities—Limitations on Liens on Common Stock of Designated Subsidiaries” and “Description of Debt Securities—Consolidation, Merger and Sale of Assets” in the accompanying prospectus. General We are issuing $ in aggregate principal amount of -Year Notes. The -Year Notes will mature on , , and will bear interest at a rate of % per annum. We are issuing $ in aggregate principal amount of -Year Notes. The -Year Notes will mature on , , and will bear interest at a rate of % per annum. We are issuing $ in aggregate principal amount of -Year Notes. The -Year Notes will mature on , , and will bear interest at a rate of % per annum. We are issuing $ in aggregate principal amount of -Year Notes. The -Year Notes will mature on , , and will bear interest at a rate of % per annum. For purposes of this “Description of the Notes,” the term “stated maturity” of the principal of any series of Notes shall mean the date upon which such series of Notes matures as described in the preceding paragraphs under this heading “—General.” Interest on the Notes will accrue from the date of their original issuance. The -Year Notes, the -Year Notes, the -Year Notes and the -Year Notes will constitute separate series under the Indenture. In the future, we may, without the consent of the holders of any series of Notes, increase the principal amounts of any series of Notes offered hereby. The Notes of each series and any additional Notes of such series subsequently issued under the Indenture will be treated as a single series or class for all purposes under the Indenture, including, without limitation, waivers, amendments and redemptions. We will issue the Notes only in fully registered form, without coupons, in denominations of $2,000 and multiples of $1,000 in